1-2 of 2
Jan L. de Bleecker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations

Available to Purchase
Subject Area:
Neurology and Neuroscience
Guntis Karelis, Rodica Balasa, Jan L. De Bleecker, Tima Stuchevskaya, Andres Villa, Philip Van Damme, Emmeline Lagrange, Jeannine M. Heckmann, Michael Nicolle, Crisandra Vilciu, Vera Bril, Elsa Mondou, Rhonda Griffin, Junliang Chen, Waleska Henriquez, Beatriz Garcia, Sandra Camprubi, Jaume Ayguasanosa
Journal: European Neurology
Eur Neurol (2019) 81 (5-6): 223–230.
https://doi.org/10.1159/000502818
Published Online: 19 November 2019
View articletitled, A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations
Open the PDF for A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations in another window
Journal Articles

Reversible Visual Deficit and Corpus callosum Lesions due to Metronidazole Toxicity

Available to Purchase
Subject Area:
Neurology and Neuroscience
Jan L. de Bleecker, Bart P. Leroy, Veronique I. Meire
Journal: European Neurology
Eur Neurol (2005) 53 (2): 93–95.
https://doi.org/10.1159/000085506
Published Online: 23 May 2005
View articletitled, Reversible Visual Deficit and Corpus callosum Lesions due to Metronidazole Toxicity
Open the PDF for Reversible Visual Deficit and Corpus callosum Lesions due to Metronidazole Toxicity in another window